RADAR Survey
Radioligand Awareness Research for NEN and Prostate Cancer
SPARC-Europe is conducting a Radioligand Awareness Research (RADAR) to understand how cancer patients and their treating physicians understand, experience and access RLT. The data collected in these surveys will inform both European and national policies aimed at enhancing the availability and accessibility of RLT. Currently, there exists a lack of understanding on the patient and physician experience and access to RLT. By collecting this information the survey findings can be translated into policy recommendations, guiding policymakers in establishing a clear pathway to institutionalise this lifesaving treatment.